NNNN vs OBCK: Side-by-Side Comparison
Compare Anbio Biotechnology - Class A (NNNN) and Ottobock SE & Co. KGaA (OBCK) side by side: market cap USD 557.42M vs EUR 3.28B. Financials, growth and model signals on Bullrun.
| Metric | NNNN | OBCK |
|---|---|---|
| Company | Anbio Biotechnology - Class A | Ottobock SE & Co. KGaA |
| Country / Exchange | Germany · NASDAQ | Germany · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
| Market cap | USD 557.42M | EUR 3.28B |
| P/E ratio | — | 35.7 |
| Dividend yield | — | 1.89% |
| Valuation model | — | 3.8% overvalued |
| Revenue (FY2025) | USD 8.65M | EUR 1.68B |
| Revenue growth YoY | +5.6% | +4.7% |
| Net income | USD 6.40M | EUR 90.20M |
| Gross margin | 87.2% | 52.8% |
| Diluted EPS | 0.15 | 1.44 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.